{"schema_version":"secwatch.filing_event.v1","accession":"0001447362-22-000109","form_type":"8-K","ticker":"CSTL","cik":"0001447362","company_name":"CASTLE BIOSCIENCES INC","filed_at":"2022-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.761809+00:00","generated_at":"2026-06-25T03:29:42.788032+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Stockholders reject advisory say-on-pay proposal at Castle Biosciences annual meeting","bullets":["Say-on-pay failed: 8,331,458 For vs 11,985,739 Against; broker non-votes 1,869,015.","Class III directors Kimberlee S. Caple, G. Bradley Cole, and Derek J. Maetzold re-elected.","Ratified KPMG LLP as independent auditor for fiscal year 2022 (22,499,340 For).","Advisory vote on frequency: 20,368,320 preferred 1 year; board will hold annual say-on-pay votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001447362-22-000109","json":"https://secwatch.observer/filing/0001447362-22-000109.json","markdown":"https://secwatch.observer/filing/0001447362-22-000109.md","text":"https://secwatch.observer/filing/0001447362-22-000109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000109/0001447362-22-000109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000109/cstl-20220602.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:29:42.788032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}